scholarly article | Q13442814 |
P2093 | author name string | Pei Wang | |
Rujun Gong | |||
Zhangsuo Liu | |||
Yan Ge | |||
Lance D Dworkin | |||
Deepak K Malhotra | |||
Bohan Chen | |||
Xianhui Liang | |||
P2860 | cites work | Mechanism of cyclosporine A nephrotoxicity: Oxidative stress, autophagy, and signalings | Q89361940 |
Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/GADD45B | Q90323241 | ||
GSK-3: tricks of the trade for a multi-tasking kinase | Q24624069 | ||
Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases | Q24626931 | ||
Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation | Q28140761 | ||
Glycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo | Q33293406 | ||
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. | Q33943247 | ||
Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy | Q34302891 | ||
Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. | Q34431548 | ||
Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion | Q35121215 | ||
Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury | Q35667727 | ||
Triptolide Inhibited Cytotoxicity of Differentiated PC12 Cells Induced by Amyloid-Beta₂₅₋₃₅ via the Autophagy Pathway | Q35837162 | ||
Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study | Q35861417 | ||
The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury | Q36545412 | ||
The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy | Q36803722 | ||
The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? | Q37036457 | ||
The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo. | Q37142515 | ||
Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy | Q37207268 | ||
Podocytes: the Weakest Link in Diabetic Kidney Disease? | Q37340690 | ||
Actin-associated Proteins in the Pathogenesis of Podocyte Injury | Q37402598 | ||
Glycogen synthase kinase‑3β is required for epithelial‑mesenchymal transition and barrier dysfunction in mouse podocytes under high glucose conditions | Q37403209 | ||
The Adverse Effects of Triptolide on the Reproductive System of Caenorhabditis elegans: Oogenesis Impairment and Decreased Oocyte Quality | Q37691095 | ||
Use of antioxidants to prevent cyclosporine a toxicity | Q38166348 | ||
Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells | Q38788707 | ||
Podocyte injury and its consequences | Q38831456 | ||
Toxicity of triptolide and the molecular mechanisms involved | Q39237694 | ||
GSK3, snail, and adhesion molecule regulation by cyclosporine A in renal tubular cells. | Q39380020 | ||
Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. | Q39432190 | ||
Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. | Q39717376 | ||
Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells | Q39816126 | ||
Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53. | Q39994742 | ||
Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury | Q41601375 | ||
Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis. | Q42049689 | ||
Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy | Q42141815 | ||
Reactive oxygen species-regulated glycogen synthase kinase-3β activation contributes to all-trans retinoic acid-induced apoptosis in granulocyte-differentiated HL60 cells. | Q42233579 | ||
Cyclosporine A-induced apoptosis in renal tubular cells is related to oxidative damage and mitochondrial fission | Q42713264 | ||
Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy | Q43059651 | ||
Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade | Q46466275 | ||
Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro | Q46570250 | ||
High glucose-induced apoptosis through store-operated calcium entry and calcineurin in human umbilical vein endothelial cells | Q46769099 | ||
Triptolide attenuates oxidative stress, NF-kappaB activation and multiple cytokine gene expression in murine peritoneal macrophage. | Q46835698 | ||
Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway | Q46968759 | ||
Efficacy and safety of Tripterygium wilfordii Hook F for CKD in Mainland China: A systematic review and meta-analysis. | Q48201892 | ||
The Evolving Complexity of the Podocyte Cytoskeleton | Q50231801 | ||
The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. | Q55004397 | ||
Traditional Chinese Medicine for Refractory Nephrotic Syndrome: Strategies and Promising Treatments. | Q55005671 | ||
Efficacy and Safety of Tripterygium Wilfordii Hook F on Psoriasis Vulgaris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Q55042900 | ||
A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F. | Q55407628 | ||
Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease | Q58758555 | ||
A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome. | Q64932016 | ||
Tumor inhibitors. LXXIV. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii | Q70479646 | ||
Role of peroxynitrite in endothelial damage mediated by Cyclosporine A | Q79517466 | ||
Cyclosporin A and tacrolimus induce renal Erk1/2 pathway via ROS-induced and metalloproteinase-dependent EGF-receptor signaling | Q82597123 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 3 | |
P921 | main subject | cyclosporine | Q367700 |
P304 | page(s) | 800-812 | |
P577 | publication date | 2020-03-15 | |
P1433 | published in | American Journal of Translational Research | Q4744272 |
P1476 | title | Triptolide potentiates the cytoskeleton-stabilizing activity of cyclosporine A in glomerular podocytes via a GSK3β dependent mechanism | |
P478 | volume | 12 |
Search more.